MedTrace Logo

International CIPN Assessment and Validation Study

NCT04633655 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-07-25

No results posted yet for this study

Summary

This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an international multi-center study.

Conditions

  • Chemotherapy-induced Peripheral Neuropathy
  • Quality of Life

Interventions

OTHER

outcome measures for CIPN testing

questionnaires administration, physician based scales for CIPN data collection

Sponsors & Collaborators

  • University of Milano Bicocca

    lead OTHER

Principal Investigators

  • GUIDO CAVALETTI, MD · University of Milano Bicocca

  • PAOLA ALBERTI, MD · University of Milano Bicocca

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-08
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States
  • Australia
  • Austria
  • Bangladesh
  • Brazil
  • Canada
  • Denmark
  • France
  • Germany
  • Greece
  • Italy
  • Kenya
  • Portugal
  • South Korea
  • Spain
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04633655 on ClinicalTrials.gov